image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3006
-7.27 %
$ 12.5 M
Market Cap
-0.22
P/E
CASH FLOW STATEMENT
-49.3 M OPERATING CASH FLOW
18.22%
33.5 M INVESTING CASH FLOW
21.09%
5.2 M FINANCING CASH FLOW
3535.66%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Rallybio Corporation
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)202020202021202120222022202320232024202420252025
Net Income -57.8 M
Depreciation & Amortization 131 K
Capital Expenditures 0
Stock-Based Compensation 7.99 M
Change in Working Capital -258 K
Others 1.07 M
Free Cash Flow -49.3 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
OPERATING CASH FLOW
Net Income (57.8) (74.6) (66.7) (47.0) (26.4) (17.6)
Depreciation & Amortization 0.1 0.1 0.2 0.1 62 K 26 K
Deferred Income Tax 0 0 0 0 0 0.1
Stock Based Compensation 8.0 10.9 9.5 3.6 0.7 0.2
Other Operating Activities 0.6 (1.0) 0.6 1.5 1.5 0.1
Change in Working Capital (0.3) 4.3 (0.9) (3.8) 2.1 2.1
Cash From Operations (49.3) (60.3) (57.3) (45.5) (22.0) (15.0)
INVESTING CASH FLOW
Capital Expenditures 0 12 K 54 K (0.3) (0.1) (0.2)
Other Items 33.5 27.7 (112.1) (2.0) (1.9) 0
Cash From Investing Activities 33.5 27.7 (112.2) (2.3) (2.1) (0.2)
FINANCING CASH FLOW
Common Stock Repurchased 62 K 0.3 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0
Other Financing Activities (0.2) 0.1 (0.5) (3.2) (0.3) 33 K
Cash From Financing Activities 5.2 0.1 51.1 83.0 144.9 31.6
CHANGE IN CASH
Net Change In Cash (10.6) (32.5) (118.4) 35.1 120.8 16.4
FREE CASH FLOW
Free Cash Flow (49.3) (60.3) (57.3) (45.9) (22.2) (15.2)